(Q51818901)
Statements
The effects of natalizumab on inflammatory mediators in multiple sclerosis: prospects for treatment-sensitive biomarkers. (English)
1 reference
1 reference
1 reference
T Olsson
1 reference
M Andersson
1 reference
L Bornsen
1 reference
F Rafatnia
1 reference
F Piehl
1 reference
1 April 2009
1 reference
16
1 reference
4
1 reference
528-536
1 reference
Identifiers
1 reference